Literature DB >> 24122445

Latest developments in the biology and management of uveal melanoma.

Sapna P Patel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24122445     DOI： 10.1007/s11912-013-0348-y

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN： 1523-3790            Impact factor:   5.075


× No keyword cloud information.
  76 in total

1.  Nonrandom chromosomal abnormalities in primary uveal melanoma.

Authors:  G Prescher; N Bornfeld; R Becher
Journal:  J Natl Cancer Inst       Date:  1990-11-21       Impact factor: 13.506

2.  Combination small molecule MEK and PI3K inhibition enhances uveal melanoma cell death in a mutant GNAQ- and GNA11-dependent manner.

Authors:  Jahan S Khalili; Xiaoxing Yu; Ji Wang; Brendan C Hayes; Michael A Davies; Gregory Lizee; Bita Esmaeli; Scott E Woodman
Journal:  Clin Cancer Res       Date:  2012-06-25       Impact factor: 12.531

3.  Uveal melanoma. Comparison of the prognostic value of fibrovascular loops, mean of the ten largest nucleoli, cell type, and tumor size.

Authors:  I W McLean; K S Keefe; M N Burnier
Journal:  Ophthalmology       Date:  1997-05       Impact factor: 12.079

Review 4.  Prognostication in eye cancer: the latest tumor, node, metastasis classification and beyond.

Authors:  T Kivelä; E Kujala
Journal:  Eye (Lond)       Date:  2012-12-21       Impact factor: 3.775

5.  Hepatic artery chemoembolization in patients with ocular melanoma metastatic to the liver: response, survival, and prognostic factors.

Authors:  Sanjay Gupta; Agop Y Bedikian; Judy Ahrar; Joe Ensor; Kamran Ahrar; David C Madoff; Michael J Wallace; Ravi Murthy; Alda Tam; Patrick Hwu
Journal:  Am J Clin Oncol       Date:  2010-10       Impact factor: 2.339

6.  Very long-term prognosis of patients with malignant uveal melanoma.

Authors:  Emma Kujala; Teemu Mäkitie; Tero Kivelä
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-11       Impact factor: 4.799

7.  Adjuvant intra-arterial hepatic fotemustine for high-risk uveal melanoma patients.

Authors:  Verena Voelter; Ann Schalenbourg; Sandro Pampallona; Solange Peters; Nermin Halkic; Alban Denys; Gudrun Goitein; Leonidas Zografos; Serge Leyvraz
Journal:  Melanoma Res       Date:  2008-06       Impact factor: 3.599

8.  Intra-arterial hepatic fotemustine for the treatment of liver metastases from uveal melanoma: experience in 101 patients.

Authors:  S Peters; V Voelter; L Zografos; S Pampallona; R Popescu; M Gillet; W Bosshard; G Fiorentini; M Lotem; R Weitzen; U Keilholz; Y Humblet; S Piperno-Neumann; R Stupp; S Leyvraz
Journal:  Ann Oncol       Date:  2006-02-09       Impact factor: 32.976

9.  Radiation-related cancer risk associated with surveillance imaging for metastasis from choroidal melanoma.

Authors:  Joanne C Wen; Victor Sai; Bradley R Straatsma; Tara A McCannel
Journal:  JAMA Ophthalmol       Date:  2013-01       Impact factor: 7.389

10.  Ultradeep sequencing detects GNAQ and GNA11 mutations in cell-free DNA from plasma of patients with uveal melanoma.

Authors:  Claudia Hd Metz; Max Scheulen; Norbert Bornfeld; Dietmar Lohmann; Michael Zeschnigk
Journal:  Cancer Med       Date:  2013-02-14       Impact factor: 4.452
View more
  12 in total

Review 1.  Immunotherapy for uveal melanoma.

Authors:  Dae Won Kim; Jaime Anderson; Sapna P Patel
Journal:  Melanoma Manag       Date:  2016-05-19

2.  Clinical presentation and management of uveal melanoma.

Authors:  Abelardo Rodríguez; Alfonso Dueñas-Gonzalez; Sarai Delgado-Pelayo
Journal:  Mol Clin Oncol       Date:  2016-09-27

3.  Phase I/II Study of Hepatic Arterial Infusion of Nab-paclitaxel in Patients With Metastatic Melanoma to the Liver.

Authors:  Jesus Vera-Aguilera; Agop Y Bedikian; Roland L Bassett; Wen-Jen Hwu; Kevin B Kim; Yong Qin; Suzanne Cain; Edwina W Washington; Michael A Davies; Sunil M Patel; Jade Homsi; Nicholas E Papadopoulos; Patrick Hwu; Sapna P Patel
Journal:  Am J Clin Oncol       Date:  2018-11       Impact factor: 2.339

4.  Long noncoding RNA MALAT1 promotes uveal melanoma cell growth and invasion by silencing of miR-140.

Authors:  Lei Sun; Peng Sun; Qi-Ying Zhou; Xiangchun Gao; Qing Han
Journal:  Am J Transl Res       Date:  2016-09-15       Impact factor: 4.060

5.  [Screening of drugs that selectively inhibit uveal melanoma cells with SF3B1 mutations].

Authors:  X Luo; C Ren; X Liu; G Zhang; S Huang; L Yu; Y Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-12-20

6.  Tumour Expression of Histone Deacetylases in Uveal Melanoma.

Authors:  Louis Levinzon; Michele Madigan; Vuong Nguyen; Enisa Hasic; Max Conway; Svetlana Cherepanoff
Journal:  Ocul Oncol Pathol       Date:  2018-09-18

Review 7.  MicroRNA dysregulation in uveal melanoma: a new player enters the game.

Authors:  Zheng Li; Xin Yu; Jianxiong Shen; Yang Jiang
Journal:  Oncotarget       Date:  2015-03-10

8.  Long non-coding RNA FTH1P3 facilitates uveal melanoma cell growth and invasion through miR-224-5p.

Authors:  Xiaoli Zheng; Hongwei Tang; Xiaofeng Zhao; Yamei Sun; Yanfang Jiang; Yonghua Liu
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

9.  Construction of a Promising Tumor-Infiltrating CD8+ T Cells Gene Signature to Improve Prediction of the Prognosis and Immune Response of Uveal Melanoma.

Authors:  Yifang Sun; Jian Wu; Yonggang Yuan; Yumin Lu; Ming Luo; Ling Lin; Shengsheng Ma
Journal:  Front Cell Dev Biol       Date:  2021-05-28

10.  Class III-specific HDAC inhibitor Tenovin-6 induces apoptosis, suppresses migration and eliminates cancer stem cells in uveal melanoma.

Authors:  Wei Dai; Jingfeng Zhou; Bei Jin; Jingxuan Pan
Journal:  Sci Rep       Date:  2016-03-04       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.